Yes , while other companies have shifted gear and some pivoting to take advantage of lower regulations ,, if ever there was a reason to expedite trialing it would be a Global Pandemic and deaths in the Millions...
Still the lowest valued Phase II oncology company on the ASX,, even with out a covid treatment ,, cancer trialing after MND ,, with years of data behind them,,, Tick Tock $$
Leiden Data will be the catalyst that we need to push up the SP as a Phase II Human Cancer Trial starts at $3m so PAA need the cash to trial ,,
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-511
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |